Dr. Pellecchia is a chemical biologist with a strong background in pharmaceutical chemistry, biophysics and translational medicine. He trained at the University of Naples (Italy) where he obtained a MS in Organic Chemistry and a Ph.D. in Pharmaceutical Sciences, at the ETH-Zurich (working with 2002 Nobel Laureate Prof. Dr. Kurt Wüthrich) and the University of Michigan. Prior to his recruitment in 2002 at the Burnham Institute for Medical Research as Associate Professor, he spent a few years in the pharmaceutical industry. He has served on the faculty of the now Sanford Burnham Prebys medical Discovery Institute for 14 years where he also served as the Associate Director for Translational Research for the Institute’s NCI designated Cancer Center.
Since 2015 he is a Professor of Biomedical Sciences at the University of California at Riverside, School of Medicine and I hold the Daniel Hays endowed Chair in Cancer Research. In addition is the Director of the Center for Molecular and Translational Medicine at UCR. His research is at the forefront of academic drug discovery andchemical biology initiatives. His goals are to support target identification and validation studies in oncology, neurodegenerative, and infectious diseases. The laboratory focuses primarily on the development of innovative pharmacological agents and subsequently apply such agents in target validation studies using cellular and animal models, both internally and via collaborations. Central to these activities are the developing and the application of novel methods and strategies to drug discovery and translational medicine.